Deal payment carves into Biogen Idec's profit By: MarketWatch July 16, 2009 at 11:41 AM EDT Biogen Idec reports lower second-quarter earnings, due in part to a payment to Acorda Therapeutics under a newly signed partnering deal. Read More >> Related Stocks: Acorda Therapeutics Biogen Idec Roche Holding AG Basel American Depositary Shares